Q-omics provides the consensus-scored RNU6-347P profile across patient tissues and cancer cell-line models. RNU6-347P expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in LUSC. Additionally, RNU6-347P RNA expression shows 6,072 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LUSC, and STAD as cancer lineages where RNU6-347P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNU6-347P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RNU6-347P survival associations across molecular data types. RNU6-347P RNA expression shows survival associations in the most cancer types (9). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU6-347P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	9	LUSC (90)	view →

This table ranks reproducible RNU6-347P RNA expression–survival associations across cancer types. High RNU6-347P expression shows unfavorable associations in LUSC, COAD, KIRC, BRCA, KICH and SKCM. The LUSC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LUSC as the clearest survival context for RNU6-347P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	II,III,IV	0.335	0.639	<.001	90	view →
COAD	OS	Tertile	All	0.140	0.871	<.001	81	view →
KIRC	DFS	Tertile	IV	0.241	0.618	.006	60	view →
BRCA	DFS	Tertile	II,III,IV	0.670	0.944	<.001	48	view →
KICH	DFS	Tertile	All	0.102	0.848	.004	39	view →
SKCM	OS	Tertile	III,IV	0.230	0.721	.004	36	view →

Pink = unfavorable, green = favorable. all 9 lineages →

RNU6-347P-LUSC (OS)

Kaplan–Meier survival curve for RNU6-347P RNA expression in LUSC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RNU6-347P in patient tissues and cancer cell lines. In patient samples, RNU6-347P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	6,072	STAD (5928)	view →
RNA	5,263	COAD (1916)	view →